T. Rowe Price Associates Portfolio
T. Rowe Price Associates 13F filer (CIK 0000080255).
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q3 2026 · 3242 positions · Total reported value $993.38B · Top-10 concentration 35.5% · Updated 2026-11-17
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
Turnover: 33.9% · 79 new · 962 cut · 88 exited
Active Share (vs S&P 500): 30.3% · vs QQQ: 51.8% — share of the book that differs from index weights (higher = more active) · ranking
In its Q3 2026 13F filing, T. Rowe Price Associates disclosed 3242 equity positions with a combined reported value of $993.38B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 35.5% of reported value. HoldingsHub classifies the profile as Mega / Technology Tilt / High Turnover.
The largest disclosed positions as of Q3 2026 were NVDA ($84.37B), AAPL ($52.04B), MSFT ($46.57B). By sector, the heaviest allocations are Technology 45.7%, Consumer Discretionary 13.7%. Versus the prior quarter, allocation shifted toward Technology (+3.5pp) and away from Financials (-0.7pp), Consumer Discretionary (-0.7pp).
Versus the prior quarter, T. Rowe Price Associates opened 79 new positions, trimmed 962 and fully exited 88, a turnover rate of 33.9% of positions. The portfolio's overlap with the prior quarter was 94% of names.
The largest new positions opened in Q3 2026 were SKHY ($1.93B), MFP ($153.09M), XME ($129.33M).
Of the 88 positions fully exited versus the prior quarter, the largest were AVB ($766.19K), BK ($504.90K).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q3 2026)
- SKHY SK HYNIX INC · $1.93B
- MFP MIDERA FOOD PROCESSING · $153.09M
- XME SPDR SERIES TRUST · $129.33M
- TIER T ROWE PRICE EXCHANGE-TRADED · $98.78M
- CMPS COMPASS PATHWAYS PLC · $28.25M
- HELP CYBIN INC · $15.59M
- ARTV ARTIVA BIOTHERPTCS INC · $13.67M
- STVN STEVANATO GROUP S P A · $12.97M
Insider Transactions (Form 4)
Latest T. Rowe Price Associates buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
T. Rowe Price Associates is a leading investment management firm founded by Thomas Rowe Price Jr. in 1937, headquartered in Baltimore, Maryland, known for its growth stock investing approach.
Investment Approach
T. Rowe Price employs a research-driven investment approach, focusing on long-term growth stock investing. The company emphasizes fundamental analysis and seeks companies with long-term growth potential.
Asset Classes
The firm manages various asset classes including equities, fixed income, alternative investments, and multi-asset strategies. They offer mutual funds, separate account management, and sub-advisory services.
Notable Facts
T. Rowe Price is one of the largest asset management firms in the United States with offices in multiple countries worldwide. The firm is known for its conservative investment style and long-term performance track record.
Key People
CEO is Joe E. Sullivan, and the firm has a team of experienced portfolio managers, including several investment specialists with expertise in various sectors.
Official disclosures are available on the SEC website.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
369.43M | $84.37B | 8.49% | Hold | |
| 2 |
|
156.27M | $52.04B | 5.24% | Reduce | |
| 3 |
|
90.80M | $46.57B | 4.69% | Add | |
| 4 |
|
99.23M | $34.14B | 3.44% | Reduce | |
| 5 |
|
113.05M | $28.17B | 2.83% | Add | |
| 6 |
|
77.62M | $27.26B | 2.74% | Reduce | |
| 7 |
|
36.66M | $22.43B | 2.26% | Add | |
| 8 |
|
30.45M | $22.08B | 2.22% | Reduce | |
| 9 |
|
58.01M | $19.77B | 1.99% | Reduce | |
| 10 |
|
13.38M | $15.49B | 1.56% | Reduce | |
| 11 |
|
11.70M | $12.46B | 1.25% | Reduce | |
| 12 |
|
32.82M | $11.79B | 1.19% | Reduce | |
| 13 |
|
17.53M | $9.67B | 0.97% | Reduce | |
| 14 |
|
27.73M | $9.17B | 0.92% | Hold | |
| 15 |
|
24.35M | $8.64B | 0.87% | Reduce | |
| 16 |
|
22.17M | $8.14B | 0.82% | Reduce | |
| 17 |
|
60.98M | $7.33B | 0.74% | Add | |
| 18 |
|
20.34M | $6.68B | 0.67% | Reduce | |
| 19 |
|
90.90M | $6.32B | 0.64% | Reduce | |
| 20 |
|
72.08M | $6.08B | 0.61% | Add | |
| 21 |
|
11.49M | $5.87B | 0.59% | Reduce | |
| 22 |
|
35.86M | $5.84B | 0.59% | Reduce | |
| 23 |
|
18.68M | $5.83B | 0.59% | Reduce | |
| 24 |
|
21.95M | $5.81B | 0.58% | Reduce | |
| 25 |
|
12.37M | $5.64B | 0.57% | Add | |
| 26 |
|
11.23M | $5.33B | 0.54% | Reduce | |
| 27 |
|
10.62M | $5.29B | 0.53% | Add | |
| 28 |
|
80.01M | $5.00B | 0.50% | Reduce | |
| 29 |
|
39.57M | $4.95B | 0.50% | Reduce | |
| 30 |
|
21.08M | $4.85B | 0.49% | Add | |
| 31 |
|
44.87M | $4.83B | 0.49% | Add | |
| 32 |
|
46.60M | $4.55B | 0.46% | Add | |
| 33 |
|
13.91M | $4.53B | 0.46% | Reduce | |
| 34 |
|
6.30M | $4.25B | 0.43% | Add | |
| 35 |
|
6.25M | $4.20B | 0.42% | Reduce | |
| 36 |
|
28.71M | $4.17B | 0.42% | Reduce | |
| 37 |
|
22.20M | $4.15B | 0.42% | Add | |
| 38 |
|
27.66M | $4.12B | 0.41% | Reduce | |
| 39 |
|
9.95M | $4.04B | 0.41% | Reduce | |
| 40 |
|
14.89M | $3.94B | 0.40% | Add | |
| 41 |
|
26.60M | $3.87B | 0.39% | Add | |
| 42 |
|
14.76M | $3.86B | 0.39% | Hold | |
| 43 |
|
23.45M | $3.82B | 0.39% | Reduce | |
| 44 |
|
25.51M | $3.78B | 0.38% | Add | |
| 45 |
|
18.47M | $3.76B | 0.38% | Reduce | |
| 46 |
|
2.03M | $3.68B | 0.37% | Add | |
| 47 |
|
16.20M | $3.67B | 0.37% | Add | |
| 48 |
|
17.73M | $3.62B | 0.36% | Add | |
| 49 |
|
18.71M | $3.57B | 0.36% | Reduce | |
| 50 |
|
65.03M | $3.54B | 0.36% | Reduce | |
FAQ
What did T. Rowe Price Associates buy in 2026-Q3?
In its 2026-Q3 13F filing, T. Rowe Price Associates reported 3242 equity positions worth $993.38B in aggregate; its largest disclosed positions were NVDA ($84.37B), AAPL ($52.04B), MSFT ($46.57B).
How large is T. Rowe Price Associates's portfolio?
T. Rowe Price Associates reported $993.38B of long equity holdings across 3242 positions as of 2026-Q3. Top-10 holdings account for 35.5% of reported value.
What is T. Rowe Price Associates's investment style?
HoldingsHub classifies the portfolio as Mega / Technology Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.